Nicotinic acid impairs assembly of leading edge in glioma cells

Yang,Xiangcai; Mei,Shuting; Niu,Hua; Li,Jiejing

doi:10.3892/or.2017.5757

Nicotinic acid impairs assembly of leading edge in glioma cells

Authors:
- Xiangcai Yang
- Shuting Mei
- Hua Niu
- Jiejing Li
View Affiliations

Affiliations: Department of Clinical Laboratory, The Affiliated Hospital of KMUST, Medical Faculty, Kunming University of Science and Technology, Kunming, Yunnan 650032, P.R. China, Department of Gerontology, First People's Hospital of Yunnan Province, Kunming, Yunnan 650032, P.R. China
Published online on: June 27, 2017 https://doi.org/10.3892/or.2017.5757
Pages: 829-836
Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Malignant glioma is a clinically formidable disease. It commonly leads to death within 5 years after diagnosis. Physicians are often baffled since the inevitable diffuse invasion deteriorates clinical outcomes rapidly. Therefore, cancerous infiltration presents a foremost challenge to all therapeutic strategies on glioblastoma multiforme (GBM). Previously, we demonstrated that nicotinic acid (NA) possesses a brand new function by targeting F-actin stress fibers. By treating HEK293 or NIH3T3 cells with a certain concentration of NA, the F-actin stress fiber was significantly disassembled. This notable finding inspired us to explore NA further in cancer cell lines, such as GBM cells, since F-actin stress fibers are the critical foundation of cell migration, proliferation and numerous essential signaling pathways. Expectedly, we observed that optimized concentrations of NA, 3.5 mM and 7.0 mM, detached U251 from culturing petri dishes. Moreover, 7.0 mM of NA was capable of disrupting the leading-edge assembly. Additionally, we collected paraffin specimens from 85 GBM patients and evaluated the expression pattern of paxillin. Notably, we found that discernable paxillin signals were detected in 67 out of 85 samples. Given that leading edge is critical for cancer cell migration, we propose that NA treatment may be developed into a potential therapy for malignant glioma.

View Figures

View References

1	Cuddapah VA, Robel S, Watkins S and Sontheimer H: A neurocentric perspective on glioma invasion. Nat Rev Neurosci. 15:455–465. 2014. View Article : Google Scholar : PubMed/NCBI
2	Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
3	Dandy WE: Removal of right cerebral hemisphere for certain tumors with hemiplegia: Preliminary report. J Am Med Assoc. 90:823–825. 1928. View Article : Google Scholar
4	Hou LC, Veeravagu A, Hsu AR and Tse VC: Recurrent glioblastoma multiforme: A review of natural history and management options. Neurosurg Focus. 20:E52006. View Article : Google Scholar : PubMed/NCBI
5	Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT and Horwitz AR: Cell migration: Integrating signals from front to back. Science. 302:1704–1709. 2003. View Article : Google Scholar : PubMed/NCBI
6	Beadle C, Assanah MC, Monzo P, Vallee R, Rosenfeld SS and Canoll P: The role of myosin II in glioma invasion of the brain. Mol Biol Cell. 19:3357–3368. 2008. View Article : Google Scholar : PubMed/NCBI
7	Demuth T and Berens ME: Molecular mechanisms of glioma cell migration and invasion. J Neurooncol. 70:217–228. 2004. View Article : Google Scholar : PubMed/NCBI
8	Kwiatkowska A and Symons M: Signaling determinants of glioma cell invasion. Glioma Signaling Springer. 121–141. 2013.https://doi.org/10.1007/978-94-007-4719-7_7 View Article : Google Scholar
9	Wolfenson H, Lavelin I and Geiger B: Dynamic regulation of the structure and functions of integrin adhesions. Dev Cell. 24:447–458. 2013. View Article : Google Scholar : PubMed/NCBI
10	Offermanns S: The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target. Trends Pharmacol Sci. 27:384–390. 2006. View Article : Google Scholar : PubMed/NCBI
11	Gille A, Bodor ET, Ahmed K and Offermanns S: Nicotinic acid: Pharmacological effects and mechanisms of action. Annu Rev Pharmacol Toxicol. 48:79–106. 2008. View Article : Google Scholar : PubMed/NCBI
12	Li J, Li Y, Zhang P, Niu H and Shi Y: Nicotinic acid modulates intracellular calcium concentration and disassembles the cytoskeleton. Mol Med Rep. 10:2805–2810. 2014.PubMed/NCBI
13	Ma L, Lee BH, Clifton H, Schaefer S and Zheng J: Nicotinic acid is a common regulator of heat-sensing TRPV1-4 ion channels. Sci Rep. 5:89062015. View Article : Google Scholar : PubMed/NCBI
14	Ma L, Lee BH, Mao R, Cai A, Jia Y, Clifton H, Schaefer S, Xu L and Zheng J: Nicotinic acid activates the capsaicin receptor TRPV1: Potential mechanism for cutaneous flushing. Arterioscler Thromb Vasc Biol. 34:1272–1280. 2014. View Article : Google Scholar : PubMed/NCBI
15	Sobottka SB and Berger MR: Assessment of antineoplastic agents by MTT assay: Partial underestimation of antiproliferative properties. Cancer Chemother Pharmacol. 30:385–393. 1992. View Article : Google Scholar : PubMed/NCBI
16	Qu J, Rizak JD, Li X, Li J and Ma Y: Melatonin treatment increases the transcription of cell proliferation-related genes prior to inducing cell death in C6 glioma cells in vitro. Oncol Lett. 6:347–352. 2013.PubMed/NCBI
17	Camand E, Peglion F, Osmani N, Sanson M and Etienne-Manneville S: N-cadherin expression level modulates integrin-mediated polarity and strongly impacts on the speed and directionality of glial cell migration. J Cell Sci. 125:844–857. 2012. View Article : Google Scholar : PubMed/NCBI
18	Vicente-Manzanares M, Choi CK and Horwitz AR: Integrins in cell migration - the actin connection. J Cell Sci. 122:199–206. 2009. View Article : Google Scholar : PubMed/NCBI
19	Winograd-Katz SE, Fässler R, Geiger B and Legate KR: The integrin adhesome: From genes and proteins to human disease. Nat Rev Mol Cell Biol. 15:273–288. 2014. View Article : Google Scholar : PubMed/NCBI
20	Frantz C, Stewart KM and Weaver VM: The extracellular matrix at a glance. J Cell Sci. 123:4195–4200. 2010. View Article : Google Scholar : PubMed/NCBI
21	Gilkes DM, Semenza GL and Wirtz D: Hypoxia and the extracellular matrix: Drivers of tumour metastasis. Nat Rev Cancer. 14:430–439. 2014. View Article : Google Scholar : PubMed/NCBI
22	Deakin NO and Turner CE: Paxillin comes of age. J Cell Sci. 121:2435–2444. 2008. View Article : Google Scholar : PubMed/NCBI
23	Kruchten AE, Krueger EW, Wang Y and McNiven MA: Distinct phospho-forms of cortactin differentially regulate actin polymerization and focal adhesions. Am J Physiol Cell Physiol. 295:C1113–C1122. 2008. View Article : Google Scholar : PubMed/NCBI
24	Lin Y, Wu Y, Li J, Dong C, Ye X, Chi YI, Evers BM and Zhou BP: The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine-specific demethylase 1. EMBO J. 29:1803–1816. 2010. View Article : Google Scholar : PubMed/NCBI
25	Aguilar-Cuenca R, Juanes-García A and Vicente-Manzanares M: Myosin II in mechanotransduction: Master and commander of cell migration, morphogenesis, and cancer. Cell Mol Life Sci. 71:479–492. 2014. View Article : Google Scholar : PubMed/NCBI
26	Kuo JC, Han X, Hsiao CT, Yates JR III and Waterman CM: Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for β-Pix in negative regulation of focal adhesion maturation. Nat Cell Biol. 13:383–393. 2011. View Article : Google Scholar : PubMed/NCBI
27	van den Dries K, Meddens MB, de Keijzer S, Shekhar S, Subramaniam V, Figdor CG and Cambi A: Interplay between myosin IIA-mediated contractility and actin network integrity orchestrates podosome composition and oscillations. Nat Commun. 4:14122013. View Article : Google Scholar : PubMed/NCBI
28	Audrito V, Vaisitti T, Rossi D, Gottardi D, D'Arena G, Laurenti L, Gaidano G, Malavasi F and Deaglio S: Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network. Cancer Res. 71:4473–4483. 2011. View Article : Google Scholar : PubMed/NCBI
29	Qu Y, Zhang J, Wu S, Li B, Liu S and Cheng J: SIRT1 promotes proliferation and inhibits apoptosis of human malignant glioma cell lines. Neurosci Lett. 525:168–172. 2012. View Article : Google Scholar : PubMed/NCBI
30	Sasca D, Hähnel PS, Szybinski J, Khawaja K, Kriege O, Pante SV, Bullinger L, Strand S, Strand D, Theobald M, et al: SIRT1 prevents genotoxic stress-induced p53 activation in acute myeloid leukemia. Blood. 124:121–133. 2014. View Article : Google Scholar : PubMed/NCBI
31	Li L, Wang L, Li L, Wang Z, Ho Y, McDonald T, Holyoake TL, Chen W and Bhatia R: Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib. Cancer Cell. 21:266–281. 2012. View Article : Google Scholar : PubMed/NCBI
32	Byron A, Askari JA, Humphries JD, Jacquemet G, Koper EJ, Warwood S, Choi CK, Stroud MJ, Chen CS, Knight D, et al: A proteomic approach reveals integrin activation state-dependent control of microtubule cortical targeting. Nat Commun. 6:61352015. View Article : Google Scholar : PubMed/NCBI
33	Cortesio CL, Boateng LR, Piazza TM, Bennin DA and Huttenlocher A: Calpain-mediated proteolysis of paxillin negatively regulates focal adhesion dynamics and cell migration. J Biol Chem. 286:9998–10006. 2011. View Article : Google Scholar : PubMed/NCBI
34	Offermanns S: Activation of platelet function through G protein-coupled receptors. Circ Res. 99:1293–1304. 2006. View Article : Google Scholar : PubMed/NCBI